tenk.fyi

Estrella Immunopharma, Inc.

ESLANasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$13.1M

195.1% YoY

EPS

$-0.35

191.7% YoY

Cash

$1.4M

51.0% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro